Catalyst Wire Dossier Catalyst Wire Dossier

AG181

· Agios Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AG181, covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Single and Multiple Ascending Dose Study and Food Effect Study for AG181 [Phase 1]

See pricing